Compared with primary PCa, mCRPC is enriched with CDK12 mutations (6.9% vs. 1.2% of 360 vs. 498 patients) that mostly harbor a truncated kinase domain (amino acids 728–1020) [40,41]. Here, CDK12 is linked to posterior cortical atrophy.